Martina Ubaldi
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2026
Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer.
Journal: ImmunoTargets and therapy
Published: September 16, 2025
Transbronchial Mediastinal Cryobiopsy Guided by Endobronchial Ultrasound in Addition to Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Ilo-Mediastinal Lymphadenopathy Without Obvious Primary Lung Neoplastic Lesion: A Prospective Multicenter Study.
Journal: Journal of clinical medicine
Published: August 26, 2025
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI).
Journal: Pigment cell & melanoma research
Published: August 07, 2025
The Role of Bronchoalveolar Lavage in Therapeutic Antimicrobial Choices for Hematologic Patients with Pulmonary Infiltrates.
Journal: Medicina (Kaunas, Lithuania)
Published: November 13, 2024
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study).
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 26, 2024
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Journal: EClinicalMedicine
Published: April 04, 2024
Delayed cold-type autoimmune hemolytic anemia responding to Rituximab in a melanoma patient treated with Ipilimumab and Nivolumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 20, 2023
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Journal: EClinicalMedicine
Published: May 25, 2023
Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC).
Journal: Journal of thoracic disease
Published: January 22, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026